Correction to: Ogourtsova T., Visual perceptual deficits and their contribution to walking dysfunction in individuals with post-stroke visual neglect

This article refers to:

Visual perceptual deficits and their contribution to walking dysfunction in individuals with post-stroke visual neglect

Ogourtsova, T., Archambault, P., & Lamontagne, L. (2018) Visual perceptual deficits and their contribution to walking dysfunction in individuals with post-stroke visual neglect, Neuropsychological Rehabilitation, DOI: 10.1080/09602011.2018.1454328

When the above article was first published online, there were missing subheadings in Table 4 that describes in comparison to which group the statistical analyses are performed.

The correct table is available in the next page.

Taylor & Francis apologises for this error.

Table 4. Single case analysis.

A
VP Test	Contrast Sensitivity LEFT			Contrast Sensitivity RIGHT			Shape Discrimination LEFT			Shape Discrimination RIGHT
Subject	t-value	Z score (effect size)	95% CI	t-value	Z score (effect size)	95% CI	t-value	Z score (effect size)	95% CI	t-value	Z score (effect size)	95% CI
USN+ vs. USN- Group
S1 (Hx)	4.01***	4.15	2.54-5.74	-0.75	-0.80	-1.37- -0.20	-0.15	-0.18	-0.69-0.33	-0.09	-0.09	-0.60-0.41
S2 (Hx)	3.09**	3.20	1.91-4.46	1.13	1.16	0.49-1.81	0.02	0.02	-0.47-0.53	1.12	1.16	0.48-1.80
S3 (Hx)	-0.14	-0.15	-0.65-0.36	-0.54	-0.56	-1.10- -0.01	-0.31	-0.32	-0.83-0.20	-0.38	-0.39	-0.91-0.13
S4 (Hx)	-1.64	-1.70	-2.4- -0.8	-0.75	-0.80	-1.37- -0.20	-0.32	-0.33	-0.84-0.19	-0.27	-0.28	-0.79-0.23
S5 (Hx)	1.45	1.50	0.74-2.23	-0.54	-0.56	-1.10- -0.01	19.75***	20.40	12.91-27.88	50.87***	52.54	33.30-71.77
S6	1.98*	2.05	1.13-2.94	-0.75	-0.80	-1.37- -0.20	-0.17	-0.18	-0.69-0.33	-0.01	-0.01	-0.51-0.49
S7	0.43	0.45	-0.09-0.97	-0.35	-0.36	-0.88-0.16	-0.22	-0.23	-0.73-0.28	-0.33	-0.34	-0.85-0.18
S8	1.54	1.60	0.81-2.36	-0.90	-0.93	-1.53- -0.31	-0.33	-0.34	-0.85-0.18	-0.21	-0.22	-0.730.29
S9	7.98***	8.25	5.18-11.30	9.55***	9.8	6.21- 13.50	-0.02	-0.03	-0.53-0.48	0.64	0.67	0.09-1.22
S10	-0.73	-0.75	-1.3- -0.16	-1.58	-1.63	-2.40- -0.83	-0.22	-0.23	-0.73-0.28	-0.24	-0.25	-0.76-0.26
S11	15.1***	15.60	9.86-21.32	3.93***	4.06	2.48-5.63	0.08	0.09	-0.42-0.59	-0.01	-0.01	-0.51-0.49
S12	480.92 ***	496.70	314.9-678.4	254.10 ***	262.43	166.40- 358.45	2.17*	2.25	1.27-3.20	8.01***	8.27	5.20-11.34
S13	40.3***	41.70	26.4-56.9	2.84**	2.93	1.73-4.11	0.22	0.23	-0.28-0.73	-0.21	-0.22	-0.73-0.29
S14	2.03*	2.10	1.16-3.01	1.77*	1.83	0.98-2.66	5.80***	5.99	3.73-8.24	18.45***	19.0	12.06-26.05
S15	2.13*	2.20	1.23-3.14	0.42	0.43	-0.10-0.95	0.00	0.00	-0.50-0.50	-0.08	-0.09	-0.59-0.42
USN- vs. HC Group
S16	-0.96	1.00	0.36-1.61	1.88*	1.95	1.06-2.81	-0.41	-0.42	-0.95-0.10	-1.45	-1.50	-2.23- -0.74
S17	0.80	0.82	0.22-1.40	0.73	0.75	0.16-1.31	1.66*	1.71	0.89-2.50	2.98**	3.08	1.83-4.31
S18	-0.20	-0.21	-0.71-0.30	-0.73	-0.75	-1.31- -0.16	0.06	0.07	-0.43-0.57	-1.45	-1.50	-2.23- -0.74
S19	0.00	0.00	-0.50-0.50	1.21	1.25	0.55-1.92	0.41	0.42	-0.10-0.95	-1.04	-1.08	-1.71- -0.42
S20	-0.26	-0.27	-0.78-0.24	-0.04	-0.05	-0.55-0.45	66.39***	68.57	43.47-93.66	28.80***	29.75	18.85-40.64
S21	0.60	0.62	0.05-1.16	0.14	0.15	-0.36-0.65	0.06	0.07	-0.43-0.57	-0.64	-0.66	-1.21- -0.09
S22	0.80	0.82	0.22-1.40	0.00	0.00	-0.50-0.50	0.89	0.92	0.30-1.52	2.09*	2.16	1.21-3.09
S23	-1.13	1.17	-1.8- -0.49	-2.66	-2.75	-3.86- -1.61	-1.24	-1.28	-1.96- -0.58	-1.69	-1.75	-2.55- -0.92
S24	0.53	0.55	-0.00-1.08	1.54	1.60	0.81-2.36	0.06	0.07	-0.43-0.57	-0.08	-0.08	-0.58-0.42
S25	1.53	1.58	0.80-2.34	2.76**	2.85	1.68- 4.00	0.89	0.92	0.30-1.52	-1.77	-1.83	-2.66- -0.98
S26	0.33	0.34	-0.18-0.86	-0.73	-0.75	-1.31- -0.16	2.07*	2.14	1.19-3.06	1.93*	2.00	1.09-2.87
S27	-0.06	-0.06	-0.57-0.43	-1.69	-1.70	-2.49- -0.88	-1.24	-1.28	-1.96- -0.58	0.16	0.17	-0.33-0.67
S28	0.46	0.48	-0.06-1.01	1.35	1.40	0.66-2.10	1.66*	1.71	0.89-2.50	0.40	0.42	-0.11-0.93
S29	-1.77	-1.82	-2.6- -0.97	1.79*	1.85	0.99-2.68	0.17	0.21	0.52-1.87	0.40	0.42	-0.11-0.93
S30	-1.30	-1.34	-2.0- -0.62	-0.38	-0.40	-0.92-0.13	-0.96	-1.00	-1.61- -0.36	-1.77	-1.83	-2.66- -0.98

Table 4. Continued.

B
VP Test	OF Direction LEFT			OF Direction RIGHT			OF Coherence LEFT			OF Coherence RIGHT
Subject	t-value	Z score (effect size)	95% CI	t-value	Z score (effect size)	95% CI	t-value	Z score (effect size)	95% CI	t-value	Z score (effect size)	95% CI
USN+ vs. USN- Group
S1 (Hx)	2.92**	3.09	1.79-4.22	6.93***	7.20	4.51-9.88	3.71**	3.83	2.33-5.32	4.75***	4.90	3.03-6.76
S2 (Hx)	3.60***	3.72	2.26-5.17	7.99***	8.26	5.19-11.32	0.13	0.143	-0.36-0.64	0.51	0.534	-0.01-1.06
S3 (Hx)	-0.65	-0.67	-1.2 - -0.1	0.16	0.17	0.34-0.68	-0.25	-0.25	-0.76-0.26	1.02	1.05	0.40-1.68
S4 (Hx)	-0.21	-0.22	-0.72-0.29	-0.52	-0.53	-1.0-0.01	1.90*	1.97	1.07-2.84	1.00	1.04	0.39- 1.66
S5 (Hx)	3.60***	3.72	2.26-5.17	7.99***	8.26	5.19-11.32	5.36***	5.53	3.44-7.62	5.01***	5.18	3.21-7.13
S6	0.34	0.35	0.17-0.87	2.10*	2.17	1.21-3.10	-0.23	-0.24	-0.74-0.27	0.75	0.77	0.18-1.34
S7	-0.74	-0.76	-1.3 - -0.1	-0.89	-0.85	-1.4- -0.2	0.05	0.05	0.44-0.56	1.28	1.33	0.61-2.02
S8	0.55	0.56	0.01-1.10	0.83	0.86	0.25-1.45	-0.78	-0.80	1.38- -0.21	-0.97	-1.00	-1.61- -0.36
S9	2.86**	2.95	1.75-4.14	6.66***	6.88	4.31-9.45	5.36***	5.53	3.44-7.62	5.01***	5.18	3.21-7.13
S10	-0.25	-0.26	-0.77-0.25	-0.48	-0.50	-1.0-0.04	0.04	0.04	-0.45-0.55	0.68	0.71	0.13-1.27
S11	3.60***	3.72	2.26-5.17	0.02	0.02	-0.47-0.53	0.03	0.03	-0.47-0.53	0.61	0.63	0.07-1.18
S12	3.60***	3.72	2.26-5.17	7.99***	8.26	5.19-11.32	-1.08	-1.11	-1.75- -0.45	-1.51	-1.56	-2.31- -0.78
S13	3.60***	3.72	2.26-5.17	7.99***	8.26	5.19-11.32	1.38	1.43	0.69- 2.14	3.88	4.00	2.44- 5.55
S14	2.61**	2.70	1.58-3.80	6.65***	6.86	4.29-9.42	-0.52	-0.53	-1.07-0.01	-0.91	-0.94	-1.54- -0.32
S15	3.60***	3.72	2.26-5.17	7.99***	8.26	5.19-11.32	1.35	1.40	0.66-2.11	2.20*	2.27	1.29-3.24
USN- vs. HC Group
S16	-0.47	-0.48	-1.01-0.05	-0.91	-0.94	-1.54- -0.31	-0.98	-1.01	-1.62- -0.37	-0.75	-0.77	-1.34- -0.18
S17	1.71*	1.77	0.93-2.58	2.27*	2.34	1.33-3.33	-1.12	-1.16	-1.81- -0.49	-0.61	-0.63	-1.18- -0.06
S18	-0.66	-0.68	-1.2- -0.1	-0.80	-0.83	-1.40- -0.22	1.11	1.14	0.47-1.79	0.68	0.70	0.12-1.26
S19	-0.55	-0.57	-1.1- -0.01	-0.65	-0.67	-1.22- -0.10	-0.09	-0.09	-0.59-0.41	-0.23	-0.24	-0.75-0.27
S20	0.87	0.90	0.28-1.49	0.03	0.03	-0.46-0.54	-0.02	-0.02	-0.53-0.48	0.16	0.17	-0.34-0.68
S21	-0.56	-0.58	-1.1- -0.02	-0.96	-1.00	-1.61- -0.36	0.60	0.62	0.06-1.17	-0.10	-0.11	-0.61-0.40
S22	4.92**	5.08	3.15-7.01	-0.57	-0.59	-1.13- -0.03	0.02	0.02	-0.48-0.53	0.35	0.36	-0.16-0.88
S23	-1.23	-1.33	-2.0- -0.62	-1.07	-1.10	-1.74- -0.44	-0.19	-0.20	-0.71-0.31	-0.43	-0.44	-0.96-0.09
S24	-0.14	-0.15	-0.65-0.36	2.00*	2.06	1.14- 2.96	-0.10	-0.11	-0.61-0.40	0.70	0.72	0.14-1.28
S25	8.17***	8.43	5.30-11.56	1.37	1.42	0.68- 2.13	2.14*	2.21	1.25- 3.16	2.43**	2.51	1.45-3.55
S26	1.22	1.26	0.56-1.93	0.52	0.54	-0.005-1.08	-0.67	-0.69	-1.24- -0.11	-0.65	-0.67	-1.23- -0.10
S27	-0.32	-0.3	-0.85-0.18	-0.56	-0.58	-1.12- -0.02	-0.13	-0.14	-0.65 -0.36	-0.73	-0.75	-1.32- -0.16
S28	0.82	0.85	0.24-1.43	0.0	0.0	-0.50-0.50	0.10	0.11	-0.40-0.61	-0.043	-0.04	-0.55-0.46
S29	2.33*	2.41	1.38-3.42	0.45	0.47	-0.07-0.99	-1.03	-1.04	-1.67- -0.39	-0.66	-0.68	-1.24- -0.11
S30	-0.73	-0.76	-1.3- -0.14	-0.86	-0.89	-1.48- -0.28	-0.90	-0.93	-1.53- -0.31	-0.82	-0.85	-1.43- -0.24

Table 4A&B Single-case analysis of single USN+ participants vs. USN- group (as control data); and single USN- participants vs. HC group (as control data) on the performance of all psychophysical tests. History (Hx); Subject (S); Optic Flow (OF); Subjects with post-stroke USN (USN+); Subjects post-stroke without USN (USN-); Healthy controls (HC); Unilateral spatial neglect (USN). Light grey selections represent individual cases whose performance is considerably worse than the comparison group (p<0.05); *, **, *** p-value <0.05, 0.01, 0.001, respectively.